Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AXICABTAGENE CILOLEUCEL Cause Immunodeficiency? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Immunodeficiency have been filed in association with AXICABTAGENE CILOLEUCEL (YESCARTA). This represents 0.2% of all adverse event reports for AXICABTAGENE CILOLEUCEL.

13
Reports of Immunodeficiency with AXICABTAGENE CILOLEUCEL
0.2%
of all AXICABTAGENE CILOLEUCEL reports
1
Deaths
8
Hospitalizations

How Dangerous Is Immunodeficiency From AXICABTAGENE CILOLEUCEL?

Of the 13 reports, 1 (7.7%) resulted in death, 8 (61.5%) required hospitalization.

Is Immunodeficiency Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AXICABTAGENE CILOLEUCEL. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does AXICABTAGENE CILOLEUCEL Cause?

Cytokine release syndrome (4,140) Immune effector cell-associated neurotoxicity syndrome (1,821) Neurotoxicity (1,327) Pyrexia (859) Death (756) Disease progression (745) Hypotension (398) Neutropenia (391) Confusional state (299) Encephalopathy (292)

What Other Drugs Cause Immunodeficiency?

ADALIMUMAB (2,981) RITUXIMAB (1,256) TOCILIZUMAB (1,061) ABATACEPT (1,042) METHOTREXATE (926) ETANERCEPT (799) INFLIXIMAB (693) CETIRIZINE (650) METHYLPREDNISOLONE (615) ALBUTEROL (599)

Which AXICABTAGENE CILOLEUCEL Alternatives Have Lower Immunodeficiency Risk?

AXICABTAGENE CILOLEUCEL vs AXITINIB AXICABTAGENE CILOLEUCEL vs AZACITIDINE AXICABTAGENE CILOLEUCEL vs AZATHIOPRINE AXICABTAGENE CILOLEUCEL vs AZD-1222 AXICABTAGENE CILOLEUCEL vs AZELAIC ACID

Related Pages

AXICABTAGENE CILOLEUCEL Full Profile All Immunodeficiency Reports All Drugs Causing Immunodeficiency AXICABTAGENE CILOLEUCEL Demographics